Defining the predictors of the placebo response in irritable bowel syndrome

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 3, 2005, Pages 237-247

  Pitz, Marshall ^a   Cheang, Mary ^a   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIGESTIVE TRACT AGENT; PLACEBO;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG EFFECT; HUMAN; IRRITABLE COLON; LINEAR REGRESSION ANALYSIS; MULTIVARIATE ANALYSIS; PREDICTION; STATISTICAL SIGNIFICANCE; SYMPTOM; SYSTEMATIC REVIEW;

CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; GASTROINTESTINAL AGENTS; HUMANS; IRRITABLE BOWEL SYNDROME; PLACEBO EFFECT;

EID: 17644374537     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00626-3     Document Type: Article

References (101)

1. H. Brody The lie that heals the ethics of giving placebos Ann Intern Med 97 1982 112 118
2. K.B. Klein Controlled treatment trials in the irritable bowel syndrome a critique Gastroenterology 95 1988 232 241
3. W.A. Brown, M.G. Johnson, M.-G. Chen Clinical features of depressed patients who do and do not improve with placebo Psychiatry Res 41 1992 203 214
4. B.T. Walsh, S.N. Seidman, R. Sysko Placebo response in studies of major depression. variable, substantial, and growing JAMA 287 2002 1840 1847
5. A.J.M. De Craen, D.E. Moerman, S.H. Heisterkamp Placebo effect in the treatment of duodenal ulcer Br J Clin Pharmacol 48 1999 853 860
6. A. Ilnyckyj, F. Shanahan, P.A. Anton Quantification of the placebo response in ulcerative colitis Gastroenterology 112 1997 1854 1858
7. N. Shetty, J.H. Friedman, K. Kieburtz The Parkinson Study Group The placebo response in Parkinson's disease Clin Neuropharmacol 22 1999 207 212
8. A.K. Schapiro Factors contributing to the placebo effect. Their implications for psychotherapy Am J Psychother 18 1964 73 88
9. J.A. Welge, P.E. Keck Jr. Moderators of placebo response to antipsychotic treatment in patients with schizophrenia a meta-regression Psychopharmacology 166 2003 1 10
10. S.A. Müller-Lissner, I. Fumagalli, K.D. Bardhan Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation Aliment Pharmacol Ther 15 2001 1655 1666
11. M. Camilleri, A.R. Northcutt, S. Kong Efficacy and safety of alosetron in women with irritable bowel syndrome a randomised, placebo-controlled trial Lancet 355 2000 1035 1039
12. J.R. Mathias, M.H. Clench, V.G. Reeves-Darby Effect of leuprolide acetate in patients with moderate to severe functional bowel disease Dig Dis Sci 39 1994 1155 1162
13. J. Snook, H.A. Shepherd Bran supplementation in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 8 1994 511 514
14. A. Jalihal, G. Kurian Ispaghula therapy in irritable bowel syndrome improvement in overall well-being is related to reduction in bowel dissatisfaction J Gastroenterol Hepatol 5 1990 507 513
15. F. Baldi, A. Longanesi, A. Blasi Clinical and functional evaluation of the efficacy of otilonium bromide a multicenter study in Italy Ital J Gastroenterol 23 Suppl 1 1991 60 63
16. R. Awad, M. Dibilox, F. Ortiz Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial Acta Gastroenterol Latinoam 25 1995 137 144
17. P.S. Efskind, T. Bernklev, M.H. Vatn A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome Scand J Gastroenterol 31 1996 463 468
18. M.G. Moshal, M. Herron A clinical trial of trimebutine (Mebutin) in spastic colon J Intern Med Res 7 1979 231 234
19. M. Van Outryve, R. Milo, J. Toussaint "Prokinetic" treatment of constipation-predominant irritable bowel syndrome a placebo-controlled study of Cisapride J Clin Gastroenterol 13 1991 49 57
20. G.F. Longstreth, D.D. Fox, L. Youkeles Psyllium therapy in the irritable bowel syndrome Ann Intern Med 95 1981 53 56
21. M. Dapoigny, J.L. Abitbol, B. Fraitag Efficacy of peripheral kappa agonist Fedotozine versus placebo in treatment of irritable bowel syndrome Dig Dis Sci 40 1995 2244 2248
22. A. Bensoussan, N.J. Talley, M. Hing Treatment of irritable bowel syndrome with Chinese herbal medicine JAMA 280 1998 1585 1589
23. P.G. Farup, N. Hovdenak, S. Wetterhus The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation Scand J Gastroenterol 33 1998 128 131
24. M. Camilleri, E.A. Mayer, D.A. Drossman Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist Aliment Pharmacol Ther 13 1999 1149 1159
25. V. Centonze, B.P. Imbimbo, F. Campanozzi Oral cimetropium bromide, a new anti muscarinic drug, for long-term treatment of irritable bowel syndrome Am J Gastroenterol 83 1988 1262 1266
26. G. Dobrilla, B.P. Imbimbo, L. Piazzi Long-term treatment of irritable bowel syndrome with cimetropium bromide a double blind placebo controlled clinical trial Gut 31 1990 355 358
27. A. Prior, P.J. Whorwell Double blind study of ispaghula in irritable bowel syndrome Gut 28 1987 1510 1513
28. J.H. Liu, G.H. Chen, H.Z. Yeh Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome a prospective, randomized trial J Gastroenterol 32 1997 765 768
29. K. Schutze, G. Brandstatter, B. Dragosics Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome Aliment Pharmacol Ther 11 1997 387 394
30. 2 agonist in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 2 1988 535 539
31. A.K. Nayak, D.R. Karnad, P. Abraham Metronidazole relieves symptoms in irritable bowel syndrome the confusion with so-called 'chronic amebiasis' Indian J Gastroenterol 16 1997 137 139
32. S. Passaretti, M. Guslandi, B.P. Imbimbo Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome Aliment Pharmacol Ther 3 1989 267 276
33. F. Baldi, A. Longanesi, A. Blasi Octylonium bromide in the treatment of the irritable bowel syndrome a clinical-functional study Hepatogastroenterology 39 1992 392 395
34. J. Gade, P. Thorn Paraghurt for patients with irritable bowel syndrome Scand J Prim Health Care 7 1989 23 26
35. G.M. Halpern, T. Prindiville, M. Blankenburg Treatment of irritable bowel syndrome with Lacteol Fort a randomized, double-blind, cross-over trial Am J Gastroenterol 91 1996 1579 1584
36. M.R. Lucey, M.L. Clark, J. Lowndes Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study Gut 28 1987 221 225
37. L. Tanum, U.F. Malt A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin Scand J Gastroenterol 31 1996 318 325
38. S.P. Misra, V.K. Thorat, G.K. Sachdev Long-term treatment of irritable bowel syndrome results of a randomized controlled trial QJM 73 1989 931 939
39. B. Lavo, M. Stenstam, A. Nielsen Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study Scand J Gastroenterol Suppl 130 1987 77 80
40. N. Hovdenak Loperamide treatment of the irritable bowel syndrome Scand J Gastroenterol Suppl 130 1987 81 84
41. C. Lunardi, L.M. Bambara, D. Biasi Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance Clin Exp Allergy 21 1991 569 572
42. D.S. Greenbaum, J.E. Mayle, L.E. Vanegeren Effects of desipramine on irritable bowel syndrome compared with atropine and placebo Dig Dis Sci 32 1987 257 266
43. G. Piai, G. Mazzacca Prifinium bromide in the treatment of the irritable colon syndrome Gastroenterology 77 1979 500 502
44. B.M. Tripathi, N.P. Misra, A.K. Gupta Evaluation of tricyclic compound (trimipramine) vis-à-vis placebo in irritable bowel syndrome. (Double blind randomised study) J Assoc Physicians India 31 1983 201 203
45. P. Nigam, K.K. Kapoor, C.K. Rastog Different therapeutic regimens in irritable bowel syndrome J Assoc Physicians India 32 1984 1041 1044
46. K.D. Bardhan, G. Bodemar, H. Geldof A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 14 2000 23 34
47. J. Myren, B. Lovland, S.E. Larssen A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome Scand J Gastroenterol 19 1984 835 843
48. J. Myren, H. Groth, S.E. Larssen The effect of trimipramine in patients with the irritable bowel syndrome Scand J Gastroenterol 17 1982 871 875
49. C. Tasman-Jones Mebeverine in patients with the irritable colon syndrome double blind study N Z Med J 77 1973 232 234
50. J.F. Fielding Double blind trial of trimebutine in the irritable bowel syndrome Irish Med J 73 1980 377 378
51. W. Kruis, M. Weinzierl, P. Schussler Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome Digestion 34 1986 196 201
52. M.J. Steinhart, P.Y. Wong, M.L. Zarr Therapeutic usefulness of amitriptyline in spastic colon syndrome Int J Psychiatry Med 11 1981-1982 45 55
53. J.A. Ritchie, S.C. Truelove Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk BMJ 1 1979 376 378
54. W.D.W. Rees, B.K. Evans, J. Rhodes Treating irritable bowel syndrome with peppermint oil BMJ 2 1979 835 836
55. P. Nash, S.R. Gould, D.E. Barnardo Peppermint oil does not relieve the pain of irritable bowel syndrome Br J Clin Pract 40 1986 292 293
56. M.J. Dew, B.K. Evans, J. Rhodes Peppermint oil for the irritable bowel syndrome a multicentre trial Br J Clin Pract 38 1984 394 398
57. M.J. Lancaster-Smith, B.J. Prout, T. Pinto Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity Acta Psychiatr Scand 66 1982 33 41
58. T. Lembo, R.A. Wright, B. Bagby Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome Am J Gastroenterol 96 2001 2662 2670
59. M. Camilleri, W.Y. Chey, E.A. Mayer A randomized controlled clinical trial of the serotonin type 3 receptor antagonist Alosetron in women with diarrhea-predominant irritable bowel syndrome Ach Intern Med 161 2001 1733 1740
60. D.G. Maxton, J. Morris, P.J. Whorwell Selective 5-hydroxytryptamine antagonism a role in irritable bowel syndrome and functional dyspepsia? Aliment Pharmacol Ther 10 1996 595 599
61. M. Perez-Mateo, C. Sillero, A. Cuesta Diltiazem in the treatment of the irritable bowel syndrome Int J Clin Pharmacol Res VI 1986 425 427
62. M. Rajagopalan, G. Kurian, J. John Symptom relief with amitriptyline in the irritable bowel syndrome J Gastroenterol Hepatol 13 1998 738 741
63. J. Novick, P. Miner, R. Krause A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation Aliment Pharmacol Ther 16 2002 1877 1888
64. S.P. Dunlop, D. Jenkins, K.R. Neal Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome Aliment Pharmacol Ther 18 2003 77 84
65. R.A. Awad, F. Llorens, A.L. Camelo A randomised double-blind placebo-controlled trial of lidamidine HCL in irritable bowel syndrome Acta Gastroenterol Latinoam 30 2000 169 175
66. K. Niedzielin, H. Kordecki, B. Birkenfeld A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome Eur J Gastroenterol Hepatol 13 2001 1143 1147
67. M. Glende, A.M. Morselli-Labate, G. Battaglia Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome Eur J Gastroenterol Hepatol 14 2002 1331 1338
68. J.R. Mathias, M.H. Clench, T.L. Abell Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease Dig Dis Sci 43 1998 1347 1355
69. E.A. Mayer, S. Berman, S.W.G. Derbyshire The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients Aliment Pharmacol Ther 16 2002 1357 1366
70. N.D. Hawkes, J. Rhodes, B.K. Evans Naloxone treatment for irritable bowel syndrome--a randomized controlled trial with an oral formulation Aliment Pharmacol Ther 16 2002 1649 1654
71. G. Battaglia, A.M. Morselli-Labate, E. Camarri Otilonium bromide in irritable bowel syndrome a double-blind, placebo-controlled, 15-week study Aliment Pharmacol Ther 12 1998 1003 1010
72. S.A. Mitchell, A.S. Mee, G.D. Smith Alverine citrate fails to relieve the symptoms of irritable bowel syndrome results of a double-blind, randomized, placebo-controlled trial Aliment Pharmacol Ther 16 2002 1187 1195
73. L.A. Houghton, N.A. Jackson, P.J. Whorwell 5-HT4 receptor antagonism in irritable bowel syndrome effect of SB-207266-A on rectal sensitivity and small bowel transit Aliment Pharmacol Ther 13 1999 1437 1444
74. P.A. Cann, N.W. Read, C.D. Holdsworth What is the benefit of coarse wheat bran in patients with irritable bowel syndrome Gut 25 1984 168 173
75. T.D. Bolin Use of oral sodium cromoglycate in persistent diarrhoea Gut 21 1980 848 850
76. S.M. Berman, L. Chang, B. Suyenobu Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist alosetron Gastroenterology 123 2002 969 977
77. D.A. Drossman, B.B. Toner, W.E. Whitehead Cognitive-behavioral therapy versus education and Desipramine versus placebo for moderate to severe functional bowel disorders Gastroenterology 125 2003 19 31
78. S. Sallon, E. Ben-Ayre, R. Davidson A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula Digestion 65 2002 161 171
79. J.F. Fielding Domperidone treatment in the irritable bowel syndrome Digestion 23 1982 125 127
80. J.F. Fielding Timolol treatment in the irritable bowel syndrome Digestion 22 1981 155 158
81. J. Kellow, O.Y. Lee, F.Y. Chang An Asia-Pacific, double blind, placebo controlled, randomized study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome Gut 52 2003 671 676
82. S. Nobaek, M.L. Johansson, G. Molin Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome Am J Gastroenterol 95 2000 1231 1238
83. K. Olden, R.G. DeGarmo, P. Jhingran Patient satisfaction with Alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome Am J Gastroenterol 97 2002 3139 3146
84. J.G. Page, G.M. Dirnberger Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride) J Clin Gastroenterol 3 1981 153 156
85. S.K. Yadav, A.K. Jain, S.N. Tripathi Irritable bowel syndrome therapeutic evaluation of indigenous drugs Indian J Med Res 90 1989 496 503
86. M. Pimentel, E.J. Chow, H.C. Lin Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome a double-blind, randomized, placebo-controlled study Am J Gastroenterol 98 2003 412 418
87. M. Olesen, E. Gudmand-Hoyer Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome Am J Clin Nutr 72 2000 1570 1575
88. N. Noor, P.K. Small, M.A. Loudon Effects of cisapride on symptoms and postcibal small-bowel motor function in patients with irritable bowel syndrome Scand J Gastroenterol 33 1998 605 611
89. R. Milo Use of the peripheral dopamine antagonist, domperidone, in the management of gastrointestinal symptoms in patients with irritable bowel syndrome Curr Med Res Opin 6 1980 577 583
90. L. Tanum, K. Bratveit-Johansen, U.F. Malt Fenfluramine challenge test predicts outcome in pharmacological treatment of patients with functional gastrointestinal disorder J Psychsom Res 47 1999 525 535
91. J. Soltoft, E. Gudmand-Hoyer, B. Krag A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome Lancet 1 1976 270 272
92. S. Fowlie, M.A. Eastwood, R. Prescott Irritable bowel syndrome assessment of psychological disturbance and its influence on the response to fibre supplementation J Psychosom Res 36 1992 175 180
93. R.M. Kline, J.J. Kline, J. Di Palma Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children J Pediatr 138 2001 125 128
94. R.C. Spiller Problems and challenges in the design of irritable bowel syndrome clinical trials experience from published trials Am J Med 107 1999 91S 97S
95. D. Mark, C.D. Saintonge, A. Herxheimer Harnessing placebo effects in health care Lancet 344 1994 995 998
96. E. Cardena, I. Kirsch What is so special about the placebo effect? Adv Mind Body Med 16 2000 16 19
97. D.E. Moerman, W.B. Jonas Deconstructing the placebo effect and finding the meaning response Ann Intern Med 136 2002 471 476
98. Kirsch I, Sapirstein G. Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prevention & Treatment 1998;1:Article 0002a. Available at: http://journals.apa.org/prevention/volume1/ pre0010002a.html.
99. R.A. Sternbach The effects of instructional sets on autonomic responsivity Psychophysiology 62 1962 67 72
100. E.H. Uhlenhuth, A. Canter, J.O. Neustadt The symptomatic relief of anxiety with meprobamate, phenobarbital, and placebo Am J Psychiatry 115 1959 905 910
101. W.G. Thompson, G.F. Longstreth, D.A. Drossman Functional bowel disorders and functional abdominal pain Gut 45 Suppl II 1999 II43 II47